Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
L-(−)-α-Methyldopa is a dopamine (DOPA) decarboxylase inhibitor (ED50 = 21.8 mg/kg) and has antihypertensive activity in vitro and in vivo.1,2,3 L-(−)-α-Methyldopa enters the CNS and is metabolized to form α-methylnorepinephrine which acts as an agonist at α2-adrenergic receptors.1,3 Formulations containing L-(−)-α-methyldopa are used to lower blood pressure.2 L-(−)-α-Methyldopa also improves trophoblast and endothelial cellular interactions in vitro.1
WARNING This product is not for human or veterinary use.
1. Antihypertensive methyldopa, labetalol, hydralazine, and clonidine reversed tumour necrosis factor-
2. Pharmacodyamic effects of alpha-
3. Alpha-